Reducing Urinalysis Screening Could Improve Antimicrobial Stewardship

Article

Reducing tests has benefits like better antibiotic use and fewer hospital infections. It can also prevent some cases of catheter-associated UTIs.

(Adobe Stock, unknown)

(Adobe Stock, unknown)

Limiting the urine cultures (UCX) sent for diagnostic workup of suspected infections and fever could improve antibiotic stewardship and reduce antibiotic resistance pressures, a review presented in a poster at the Association of Infection Prevention and Epidemiology Annual Conference held in Orlando, Florida, from June 26 to 28, 2023.

The poster titled “Urine Culture Lab Stewardship: Preliminary Review of Using More Stringent Urinalysis Screening for Reducing Unnecessary Urine Culture” was presented by Jorge P Parada, MD, MPH; Megan Barnes, MD, MPH; Louise Lie, MPH, CIC, all from Loyola University Medical Center in Maywood, Illinois.

“We found that the overwhelming majority of urine specimens with 6-10 WBCs on the UA were unlikely to have a UTI and did not require reflex UCX,” the authors noted.

A urinalysis (UA) measures urine white blood cells (WBC) in the urine and other elements, such as nitrites and leuks, that can be used to screen if urine is inflammatory and, therefore, infected. However, UCX can be contaminated easily, which may lead caregivers to the belief that the patient has a true bacterial infection.

The authors wrote, “In normal hosts, it is very unlikely that a patient has an infection without concomitant inflammation.” When there is inflammation, a positive UA should be reflexed for UCX.

“Prior work has shown that with rare exception, UA with fewer or equal to 5 WBCs/high-powered field (HPF) need not reflexed for UCX, while UA with 6-10 WBCs/HPF were likely to have significant bacterial growth reflecting an underlying UTI,” the authors wrote.

The authors conducted a study across multiple centers, reviewing past cases of urinary analyses with reflex urinary culture from October 1, 2019, to October 31, 2020. They focused on cases where the analysis found 6-10 white blood cells per HPF and examined the corresponding urinary cultures. They noted whether the cultures showed no, small, medium, or large amounts of bacteria or fungi. The investigators also noted if they were mono- or polymicrobial growth and whether the isolated organisms were typical pathogens or contaminants. They also reviewed clinical charts for evidence to confirm or rule out UTIs, taking note of any associated signs and symptoms.

A total of 39,855 specimens were reviewed, and 2,275 of them met the necessary criteria. Out of these, only 77 (3.4%) were found to be "abnormal" on the final UCXs. Upon reviewing the charts, it was determined that UTIs could be ruled out in all but 20 (0.9%) cases.

To optimize the utilization of lab resources, the results of the review recommended minimizing the number of urine specimens sent for UCX reflex testing. This course of action will reduce supplies and workforce usage, as there will be less requirement for plating urine into culture media, detecting microbial growth, identifying microbial isolates, and conducting antimicrobial sensitivity tests.

Reducing these tests could help, the authors wrote, could “improve antibiotic stewardship, reduce antibiotic resistance pressures, and reduce hospital-onset C difficile infection. Finally, “some cases with bacterial growth and Foley catheters would not occur and no longer be reported as catheter-associated UTIs.”

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Rare Disease Month: An Infection Control Today® and Contagion® collaboration.
Related Content